Definitely a good tactic selling half or all after a good phase 2 readout. Bios go into sleeper mode as not much happens for a couple of years and you can make money elsewhere. The tide is definitely turning here, and with low SOI the move will be aggressive.
Ann: Invex Granted Key European Patent for Exenatide, page-51
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.636M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 34884 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 2827 | 1 |
View Market Depth
| Last trade - 16.12pm 11/02/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable